Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1981 Sep-Oct;54(5):367–379.

Specific and nonspecific immunotherapy as an adjunct to curative surgery for cancer of the lung.

A C Hollinshead, T H Stewart
PMCID: PMC2596033  PMID: 7039148

Abstract

Attempts to improve survival following curative surgery for non-small-cell lung cancer are reviewed. Most of these approaches have been designed to stimulate the resistance of lung cancer patients in a non-specific fashion. Living bacteria or products of dead bacteria have been given as adjunctive treatment. Various routes have been used; oral, intradermal, subdermal, or intrapleural, with either BCG or Corynebacterium parvum. No reproducible benefit has been observed. Levamisole has not been proven to be useful. Trials have yet to be completed to confirm the use of thymosin fraction V for small cell carcinoma in improving the effectiveness of chemotherapy. A pilot trial using specific active immunotherapy is described. Prolongation of survival four years after closure of the trial in those patients immunized, compared with non-immunized patients, has prompted two further clinical trials. A small trial has confirmed the effectiveness of specific immunotherapy as adjunctive therapy for squamous cell carcinoma. A large multicenter trial in Canada and the United States should be completed and open to analysis in 1984 and may shed light on the role of tumor-associated antigens in stimulating specific resistance to lung cancer.

Full text

PDF
367

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe S., Yamazaki M., Mizuno D. Antitumor immunity after surgical removal of 3-methylcholanthrene-induced murine tumors: correlation between resistance and delayed hypersensitivity reaction. Gan. 1978 Jun;69(3):323–329. [PubMed] [Google Scholar]
  2. Anthony H. M., Mearns A. J., Mason M. K., Scott D. G., Moghissi K., Deverall P. B., Rozycki Z. J., Watson D. A. Levamisole and surgery in bronchial carcinoma patients: increase in deaths from cardiorespiratory failure. Thorax. 1979 Feb;34(1):4–12. doi: 10.1136/thx.34.1.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BRENT L., BROWN J., MEDAWAR P. B. Skin transplantation immunity in relation to hypersensitivity. Lancet. 1958 Sep 13;2(7046):561–564. doi: 10.1016/s0140-6736(58)90202-2. [DOI] [PubMed] [Google Scholar]
  4. Bell C. E., Jr A normal adult and fetal lung antigen present at different quantitative levels in different histologic types of human lung cancer. Cancer. 1976 Feb;37(2):703–713. doi: 10.1002/1097-0142(197602)37:2<706::aid-cncr2820370215>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  5. Berman L. D., Allison A. C., Pereira H. G. Effects of Freund's adjuvant on adenovirus oncogenesis and antibody production in hamsters. Int J Cancer. 1967 Sep 15;2(5):539–543. doi: 10.1002/ijc.2910020515. [DOI] [PubMed] [Google Scholar]
  6. Boddie A. W., Jr, Holmes E. C., Roth J. A., Morton D. L. Inhibition of human leukocyte migration in agarose by kcl extracts of carcinoma of the lung. Int J Cancer. 1975 May 15;15(5):823–829. doi: 10.1002/ijc.2910150514. [DOI] [PubMed] [Google Scholar]
  7. Brannen G. E., Adams J. S., Santos G. W. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens. J Natl Cancer Inst. 1974 Jul;53(1):165–175. doi: 10.1093/jnci/53.1.165. [DOI] [PubMed] [Google Scholar]
  8. Brannen G. E., Santos G. W. Immune responses to soluble tumor antigens in various stages of tumor growth. Invest Urol. 1975 Sep;13(2):79–84. [PubMed] [Google Scholar]
  9. Brohee D., Vanderhoeft P., Smets P. Lung cancer and postoperative empyema. Eur J Cancer. 1977 Dec;13(12):1429–1436. doi: 10.1016/0014-2964(77)90157-8. [DOI] [PubMed] [Google Scholar]
  10. CUTLER S. J., EDERER F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958 Dec;8(6):699–712. doi: 10.1016/0021-9681(58)90126-7. [DOI] [PubMed] [Google Scholar]
  11. Cerni C. Demonstration of tumor-associated antigens on tumor cell hybrids by means of the leucocyte-migration-inhibition-test. Oncology. 1977;34(5):216–218. doi: 10.1159/000225227. [DOI] [PubMed] [Google Scholar]
  12. Cohen M. H., Chretien P. B., Ihde D. C., Fossieck B. E., Jr, Makuch R., Bunn P. A., Jr, Johnston A. V., Shackney S. E., Matthews M. J., Lipson S. D. Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer. JAMA. 1979 Apr 27;241(17):1813–1815. doi: 10.1001/jama.241.17.1813. [DOI] [PubMed] [Google Scholar]
  13. Coley W. B. II. Contribution to the Knowledge of Sarcoma. Ann Surg. 1891 Sep;14(3):199–220. doi: 10.1097/00000658-189112000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dean J. H., Jerrells T. R., Cannon G. B., Kibrite A., Baumgardner B., Weese J. L., Silva J., Herberman R. B. Demonstration of specific cell-mediated anti-tumor immunity in lung cancer to autologous tissue extracts. Int J Cancer. 1978 Oct 15;22(4):367–377. doi: 10.1002/ijc.2910220402. [DOI] [PubMed] [Google Scholar]
  15. Di Paola M., Bertolotti A., Colizza S., Coli M. Histology of bronchial carcinoma and regional lymph nodes as putative immune response of the host to the tumor. J Thorac Cardiovasc Surg. 1977 Apr;73(4):531–537. [PubMed] [Google Scholar]
  16. Edwards F. R., Whitwell F. Use of BCG as an immunostimulant in the surgical treatment of carcinoma of lung: a five-year follow-up report. Thorax. 1978 Apr;33(2):250–252. doi: 10.1136/thx.33.2.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Frost M. J., Rogers G. T., Bagshawe K. D. Extraction and preliminary characterization of a human bronchogenic carcinoma antigen. Br J Cancer. 1975 Apr;31(4):379–386. doi: 10.1038/bjc.1975.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gehan E. A. A generalized two-sample Wilcoxon test for doubly censored data. Biometrika. 1965 Dec;52(3):650–653. [PubMed] [Google Scholar]
  19. Green N., Kern W. The clinical course and treatment results of patients with postresection locally recurrent lung cancer. Cancer. 1978 Nov;42(5):2478–2482. doi: 10.1002/1097-0142(197811)42:5<2478::aid-cncr2820420551>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  20. Hollinshead A. C., Sega E., Stewart T. H., Ricci C., Mineo T. C. A comparison of lung cancer antigens. Tumori. 1975 Mar-Apr;61(2):125–128. doi: 10.1177/030089167506100201. [DOI] [PubMed] [Google Scholar]
  21. Hollinshead A. C., Stewart T. H., Herberman R. B. Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells. J Natl Cancer Inst. 1974 Feb;52(2):327–338. doi: 10.1093/jnci/52.2.327. [DOI] [PubMed] [Google Scholar]
  22. Iles P. B., McIllmurray M. B., Baldwin R. W., Langman M. J. The LMI assay in lung and colorectal cancer: the use of allogeneic extracts prepared by different methods. Eur J Cancer. 1978 Oct;14(10):1113–1119. doi: 10.1016/0014-2964(78)90067-1. [DOI] [PubMed] [Google Scholar]
  23. Ioachim H. L. The stromal reaction of tumors: an expression of immune surveillance. J Natl Cancer Inst. 1976 Sep;57(3):465–475. doi: 10.1093/jnci/57.3.465. [DOI] [PubMed] [Google Scholar]
  24. Jamasbi R. J., Nettesheim P. Demonstration of cross-reacting tumor rejection antigens in chemically induced respiratory tract carcinomas in rats. Cancer Res. 1977 Nov;37(11):4059–4063. [PubMed] [Google Scholar]
  25. Jamasbi R. J., Nettesheim P., Kennel S. J. Demonstration of cellular and humoral immunity to transplantable carcinomas derived from the respiratory tract of rats. Cancer Res. 1978 Feb;38(2):261–267. [PubMed] [Google Scholar]
  26. Jamasbi R. J., Nettesheim P., Kennel S. J. Detection of circulating tumor antigens in mice carrying a highly metastatic pulmonary squamous--cell carcinoma. Int J Cancer. 1978 Mar 15;21(3):387–394. doi: 10.1002/ijc.2910210321. [DOI] [PubMed] [Google Scholar]
  27. Kelly B. S., Levy J. G. Tumour-associated antigens in lung cancer: the possibility for a serologic assay. Can Med Assoc J. 1980 May 10;122(9):1020–1023. [PMC free article] [PubMed] [Google Scholar]
  28. Kelly B., Levy J. G. Evidence for a common tumour-associated antigen in extracts of human bronchogenic carcinoma. Br J Cancer. 1977 Jun;35(6):828–833. doi: 10.1038/bjc.1977.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kempner D. H., Jay M. R., Stevens R. H. Human lung tumor-associated antigens of 32,000 daltons molecular weight. J Natl Cancer Inst. 1979 Nov;63(5):1121–1129. [PubMed] [Google Scholar]
  30. Lowe J., Iles P. B., Shore D. F., Langman M. J., Baldwin R. W. Intrapleural BCG in operable lung cancer. Lancet. 1980 Jan 5;1(8158):11–14. doi: 10.1016/s0140-6736(80)90551-6. [DOI] [PubMed] [Google Scholar]
  31. Martin W. J., Gipson T. G., Conliffe M., Friedman R., Dove L., Rice J. M. Common tumor-associated transplantation alloantigen detected on a proportion of lung tumors induced transplacentally in several strains of mice. Transplantation. 1977 Oct;24(4):294–296. doi: 10.1097/00007890-197710000-00011. [DOI] [PubMed] [Google Scholar]
  32. McCoy J. L., Jerome L. F., Cannon G. B., Weese J. L., Herberman R. B. Reactivity of lung cancer patients in leukocyte migration inhibition assays to 3-M potassium chloride extracts of fresh tumor and tissue-cultured cells derived from lung cancer. J Natl Cancer Inst. 1977 Nov;59(5):1413–1418. doi: 10.1093/jnci/59.5.1413. [DOI] [PubMed] [Google Scholar]
  33. Miller A. B., Taylor H. E., Baker M. A., Dodds D. J., Falk R., Frappier A., Hill D. P., Jindani A., Landi S., Macdonald A. S. Oral administration of BCG as an adjuvant to surgical treatment of carcinoma of the bronchus. Can Med Assoc J. 1979 Jul 7;121(1):45–54. [PMC free article] [PubMed] [Google Scholar]
  34. Minasian H., Lewis C. T., Evans S. J. Influence of postoperative empyema on survival after pulmonary resection for bronchogenic carcinoma. Br Med J. 1978 Nov 11;2(6148):1329–1331. doi: 10.1136/bmj.2.6148.1329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Mohr A. J., Nordquist R. E., Rhoades E. R., Coalson R. E., Coalson J. J. Alveolar cell carcinoma-like antigen and antibodies in patients with alveolar cell carcinoma and other cancers. Cancer Res. 1974 Aug;34(8):1904–1907. [PubMed] [Google Scholar]
  36. Mountain C. F., Carr D. T., Anderson W. A. A system for the clinical staging of lung cancer. Am J Roentgenol Radium Ther Nucl Med. 1974 Jan;120(1):130–138. doi: 10.2214/ajr.120.1.130. [DOI] [PubMed] [Google Scholar]
  37. Paluch E., Ioachim H. L. Lung carcinoma-reactive antibodies isolated from tumor tissues and pleural effusions of lung cancer patients. J Natl Cancer Inst. 1978 Aug;61(2):319–325. [PubMed] [Google Scholar]
  38. Pines A. A 5-year controlled study of B.C.G. and radiotherapy inoperable lung cancer. Lancet. 1976 Feb 21;1(7956):380–381. doi: 10.1016/s0140-6736(76)90213-0. [DOI] [PubMed] [Google Scholar]
  39. SHAW C. M., ALVORD E. C., Jr, KAKU J., KIES M. W. CORRELATION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS WITH DELAYED-TYPE SKIN SENSITIVITY TO SPECIFIC HOMOLOGOUS ENCEPHALITOGEN. Ann N Y Acad Sci. 1965 Mar 31;122:318–331. doi: 10.1111/j.1749-6632.1965.tb20216.x. [DOI] [PubMed] [Google Scholar]
  40. Saito T., Koshizawa M., Sato T., Muramoto T., Konishi K. I. On the development of delayed skin hypersensitivity following separate injection of antigen and Freund's complete adjuvant. Preliminary report. Jpn J Tuberc Chest Dis. 1970 Jul;16(1):44–51. [PubMed] [Google Scholar]
  41. Sanner T., Kotlar H. K., Eker P. Immune responses in lung cancer patients measured by a modified leukocyte adherence inhibition test using serum. Cancer Lett. 1980 Feb;8(4):283–290. doi: 10.1016/0304-3835(80)90143-3. [DOI] [PubMed] [Google Scholar]
  42. Sega E., Mottolese M., Curcio C. G., Citro G. Specific blastogenic response of peripheral blood lymphocytes from lung cancer patients to a fetal lung antigen. J Natl Cancer Inst. 1980 May;64(5):1001–1006. [PubMed] [Google Scholar]
  43. Stewart T. H., Hollinshead A. C., Harris J. E., Belanger R., Crepeau A., Hooper G. D., Sachs H. J., Klaassen D. J., Hirte W., Rapp E. Immunochemotherapy of lung cancer. Ann N Y Acad Sci. 1976;277(00):436–466. doi: 10.1111/j.1749-6632.1976.tb41720.x. [DOI] [PubMed] [Google Scholar]
  44. Stewart T. H., Tolnai G. The regression of an inflammatory skin lesion by the induction of a delayed hypersensitivity reaction. A case report. Cancer. 1969 Jul;24(1):117–121. doi: 10.1002/1097-0142(196907)24:1<117::aid-cncr2820240115>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  45. Thomson D. M., Tataryn D. N., Lopez M., Schwartz R., MacFarlane J. K. Human tumor-specific immunity assayed by a computerized tube leukocyte adherence inhibition. Cancer Res. 1979 Feb;39(2 Pt 2):638–643. [PubMed] [Google Scholar]
  46. Vaage J., Jones R. D., Brown B. W. Tumor-specific resistance in mice detected by inhibition of macrophage migration. Cancer Res. 1972 Apr;32(4):680–687. [PubMed] [Google Scholar]
  47. Veltri R. W., Mengoli H. F., Maxim P. E., Westfall S., Gopo J. M., Hauang C. W., Sprinkle P. M. Isolation and identification of human lung tumor-associated antigens. Cancer Res. 1977 May;37(5):1313–1322. [PubMed] [Google Scholar]
  48. Viza D., Louvier M., Phillips J., Boucheix C., Guerin R. A. Solubilization of an antigen associated with certain bronchial tumours. Eur J Cancer. 1975 Nov;11(11):765–770. doi: 10.1016/0014-2964(75)90169-3. [DOI] [PubMed] [Google Scholar]
  49. Vose B. M., Vánky F., Fopp M., Klein E. Restricted autologous lymphocytotoxicity in lung neoplasia. Br J Cancer. 1978 Sep;38(3):375–381. doi: 10.1038/bjc.1978.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Watson R. D., Smith A. G., Levy J. G. The detection by immunodiffusion of tumour associated antigenic components in extracts of human bronchongenic carcinoma. Br J Cancer. 1975 Sep;32(3):300–309. doi: 10.1038/bjc.1975.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Yoda Y., Gasa S., Makita A., Fujioka Y., Kikuchi Y., Hashimoto M. Glycolipids in human lung carcinoma of histologically different types. J Natl Cancer Inst. 1979 Nov;63(5):1153–1160. [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES